ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,567.19
      1.06%
      US Tech 100
      19,828.00
      0.95%
      Dow Jones
      39,375.87
      0.17%
      Brent Oil
      86.775
      0.00%
      Bitcoin
      57,781.13
      2.00%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Esperion Therapeutics Inc (ESPR)

      7. Esperion Therapeutics Inc (ESPR) News

      ESPR

      Esperion Therapeutics (ESPR)

      Esperion Therapeutics Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:ESPR
      DateTimeSourceHeadlineSymbolCompany
      02/14/20176:12PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ESPREsperion Therapeutics Inc
      02/14/201711:19AMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ESPREsperion Therapeutics Inc
      01/30/201711:36AMEdgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:ESPREsperion Therapeutics Inc
      01/25/20178:05AMGlobeNewswire Inc.Esperion Completes Enrollment of Pivotal Phase 3 Long-Term Safety and Tolerability Study of Bempedoic Acid in Patients with H...NASDAQ:ESPREsperion Therapeutics Inc
      01/09/20174:07PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ESPREsperion Therapeutics Inc
      01/09/20178:05AMGlobeNewswire Inc.Esperion Announces Initiation of Global Cardiovascular Outcomes Trial for Bempedoic AcidNASDAQ:ESPREsperion Therapeutics Inc
      01/08/20174:00PMGlobeNewswire Inc.Esperion Announces Initiation of Three Pivotal Phase 3 Studies for Bempedoic AcidNASDAQ:ESPREsperion Therapeutics Inc
      01/04/20175:00PMGlobeNewswire Inc.Esperion to Present at the 35th Annual J.P. Morgan Healthcare ConferenceNASDAQ:ESPREsperion Therapeutics Inc
      01/03/20176:44PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ESPREsperion Therapeutics Inc
      01/03/20176:43PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ESPREsperion Therapeutics Inc
      01/03/20176:43PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ESPREsperion Therapeutics Inc
      12/09/20164:31PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ESPREsperion Therapeutics Inc
      11/28/20164:30PMGlobeNewswire Inc.Esperion Therapeutics Announces Publication of Definitive Paper on Bempedoic Acid Mechanism of Action in Nature Communication...NASDAQ:ESPREsperion Therapeutics Inc
      11/09/20164:30PMGlobeNewswire Inc.Esperion Therapeutics to Present at the Stifel 2016 Healthcare ConferenceNASDAQ:ESPREsperion Therapeutics Inc
      11/03/20165:59PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ESPREsperion Therapeutics Inc
      11/03/20164:39PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ESPREsperion Therapeutics Inc
      11/03/20164:37PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ESPREsperion Therapeutics Inc
      11/03/20164:05PMGlobeNewswire Inc.Esperion Therapeutics Provides Bempedoic Acid Development Program Updates; Reports Third Quarter 2016 Financial ResultsNASDAQ:ESPREsperion Therapeutics Inc
      11/01/20164:30PMGlobeNewswire Inc.Esperion Therapeutics to Present at the Credit Suisse 25th Annual Healthcare ConferenceNASDAQ:ESPREsperion Therapeutics Inc
      10/13/20167:46AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ESPREsperion Therapeutics Inc
      10/13/20167:30AMGlobeNewswire Inc.Bempedoic Acid Global Phase 3 Clinical Program to Include Patients on Any Statin at Any DoseNASDAQ:ESPREsperion Therapeutics Inc
      08/04/20164:36PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ESPREsperion Therapeutics Inc
      08/04/20164:05PMGlobeNewswire Inc.Esperion Therapeutics Provides Bempedoic Acid Development Program Updates; Reports Second Quarter 2016 Financial ResultsNASDAQ:ESPREsperion Therapeutics Inc
      07/07/20167:18AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ESPREsperion Therapeutics Inc
      06/28/20164:22PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ESPREsperion Therapeutics Inc
      06/28/20164:05PMGlobeNewswire Inc.Esperion Therapeutics Provides Clinical Development and Regulatory Update for Bempedoic AcidNASDAQ:ESPREsperion Therapeutics Inc
      06/15/20164:07PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ESPREsperion Therapeutics Inc
      06/13/20164:54PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ESPREsperion Therapeutics Inc
      06/10/20166:00PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ESPREsperion Therapeutics Inc
      06/10/20165:59PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ESPREsperion Therapeutics Inc
       Showing the most relevant articles for your search:NASDAQ:ESPR